Back to Authors

Suthiwanich, Kasinan

https://orcid.org/0000-0003-3653-5050

Mayo Clinic

University Health Network

Citations 3

Tissue regenerative medicine: Clinical advances, challenges, and opportunities
Badawy, Seleem , Gopinath, Varshiny , Espinosa, Ana M. Diaz , Kelmser, Ethan C., Duke, Victoria R. , Kamaraju, Veda , Nakayama, Karina, Manna, Manoj , Liu, Julianne J-Y , Shen, K. Robert , Suthiwanich, Kasinan , Duke, Victoria , Kamaraju, Veda , Manna, Manoj , Liu, Julianne J-Y , Nunes, Sara S , Shen, Keyue , Huang, Ngan F , Diaz Espinosa, Ana M , Badawy, Seleem , Gopinath, Varshiny , Suthiwanich, Kasinan , Kelmser, Ethan C, Nakayama, Karina

APL Bioengineering | December 18, 2025 | Volume: 9 | Issue: 4 | Pages: No page available

10.1063/5.0296897 Get It

Regenerative medicine is transforming how we restore tissue function, leveraging advances in cell and molecular biology, biomaterials, and engineered microenvironments. While there have been notable advances and rapid progress over the past few decades, ongoing challenges persist in the technical development and effective translation of these advancements to clinical care. This perspective highlights clinically promising examples and critically assesses present challenges in translating tissue regenerative medicine therapies from the bench to the clinic. We further examine the evolving landscape of regenerative medicine by describing strategies to optimize the cellular microenvironment, the impact of patient demographics, and the use of artificial intelligence to shape the future of this field.
Hall of Fame Article: Minimally Invasive and Regenerative Therapeutics (Adv. Mater. 1/2019)
Ahadian, Samad , Darabi, Mohammad Ali , Lee, Junmin , Ashammakhi, Nureddin A. , Tahchi, Mario El , Suthiwanich, Kasinan , Sheikhi, Amir , Dokmeci, Mehmet R. , Öklü, Rahmi , Khademhosseini, Ali

Advanced Materials | January 3, 2019 | Volume: 31 | Issue: 1 | Pages: No page available

10.1002/adma.201970005 Get It

Minimally Invasive and Regenerative Therapeutics
Ahadian, Samad , Darabi, Mohammad Ali , Tahchi, Mario El , Lee, Junmin , Suthiwanich, Kasinan , Sheikhi, Amir , Dokmeci, Mehmet R. , Öklü, Rahmi , Khademhosseini, Ali , Khademhosseini, Ali , Khademhosseini, Ali , Oklu, Rahmi , Khademhosseini, Ali , Dokmeci, Mehmet Remzi , Ashammakhi, Nureddin A. , Suthiwanich, Kasinan

Advanced Materials | December 19, 2018 | Volume: 31 | Issue: 1 | Pages: No page available

10.1002/adma.201804041 Get It

Abstract Advances in biomaterial synthesis and fabrication, stem cell biology, bioimaging, microsurgery procedures, and microscale technologies have made minimally invasive therapeutics a viable tool in regenerative medicine. Therapeutics, herein defined as cells, biomaterials, biomolecules, and their combinations, can be delivered in a minimally invasive way to regenerate different tissues in the body, such as bone, cartilage, pancreas, cardiac, skeletal muscle, liver, skin, and neural tissues. Sophisticated methods of tracking, sensing, and stimulation of therapeutics in vivo using nano‐biomaterials and soft bioelectronic devices provide great opportunities to further develop minimally invasive and regenerative therapeutics (MIRET). In general, minimally invasive delivery methods offer high yield with low risk of complications and reduced costs compared to conventional delivery methods. Here, minimally invasive approaches for delivering regenerative therapeutics into the body are reviewed. The use of MIRET to treat different tissues and organs is described. Although some clinical trials have been performed using MIRET, it is hoped that such therapeutics find wider applications to treat patients. Finally, some future perspective and challenges for this emerging field are highlighted.